Código QR (código de barras bidimensional)

Clinical efficacy of hepatic arterial infusion chemotherapy combined with transhepatic arterial embolization plus lenvatinib and tislelizumab or transarterial chemoembolization combined with lenvatinib plus tislelizumab in the treatment of advanced hepatocellular carcinoma

PurposeAdvanced hepatocellular carcinoma (HCC) remains a challenge for clinical treatment. The purpose of this study is to compare the efficacy of a quadruple combination of hepatic arterial infusion chemotherapy (HAIC) with transhepatic arterial embolization (TAE), lenvatinib, and tislelizumab (THL...

ver descrição completa

Na minha lista:
Principais autores: Zha Peng, Yaqiong Wang, Boyu Chen, Zhuangrong Zhu, Chengyi He, Yang Wei, Hai Huang
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2025-12-01
coleção:Frontiers in Oncology
Assuntos:
hepatocellular carcinoma
transhepatic arterial embolization
hepatic arterial infusion chemotherapy
transarterial chemoembolization
lenvatinib
tislelizumab
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fonc.2025.1665348/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados